当前位置:Public Access >页面
Chinese/English
A single-arm, multicenter, open-label clinical study to evaluate the efficacy and safety of trifluridine/tipiracil combined with tislelizumab and bevacizumab in patients with third-line or later locally advanced unresectable or metastatic colorectal cancer
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
029 Woman 2025-07-21

OPD

soviet
028 Woman 2025-07-09

OPD

soviet
027 Man 2025-05-08

OPD

soviet
026 Man 2025-05-08

OPD

soviet
025 Man 2025-05-07

OPD

soviet
024 Woman 2025-03-16

OPD

soviet
023 Man 2025-02-28

OPD

soviet
022 Woman 2025-02-26

OPD

soviet
021 Man 2026-03-13

OPD

soviet
020 Woman 2025-01-24

OPD

soviet
019 Man 2024-11-01

OPD

soviet
018 Man 2024-08-16

OPD

soviet
017 Woman 2024-08-12

OPD

soviet
016 Man 2024-06-06

OPD

soviet
015 Man 2024-05-29

OPD

soviet
014 Man 2024-04-27

OPD

soviet
013 Man 2024-03-18

OPD

soviet
012 Man 2024-03-08

OPD

soviet
011 Man 2024-02-21

OPD

soviet
010 Man 2024-01-23

OPD

soviet
009 Woman 2024-01-05

OPD

soviet
008 Woman 2023-12-14

OPD

soviet
007 Man 2023-12-13

OPD

soviet
006 Man 2023-10-24

OPD

soviet
005 Man 2023-10-20

OPD

soviet